CD40LG and B-cell chronic lymphocytic leukemia: In fact, endogenous anti-ROR1 pAbs that were detected in CLL patients after vaccination with autologous CD154-transduced CLL cells [14] as well as after treatment with lenalidomide [35] suggest that anti-ROR1 mAbs are safe.